Tirzepatide for managing overweight and obesity

  • Technology appraisal guidance
  • TA1026
  • Published: 
Download (PDF)

Tirzepatide: local formulary information

References

  1. Jastreboff A, Aronne L, Ahmad N, et al. (2022) Tirzepatide once weekly for the treatment of obesity. New Eng J Med 387: 205–16 (SURMOUNT-1)

  2. Garvey W, Frias J, Jastreboff A, et al. (2023) Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 402: 613–26

ISBN: 978-1-4731-6711-7

This page was last updated: